Radiotherapy Planning, Computer-AssistedDose-Response Relationship, RadiationUltraviolet RaysProton TherapyPhysical Therapy ModalitiesNeoplasmsRadiotherapy DosageRadiometryFilm DosimetryRadiation InjuriesRadiation DosageRadiotherapy, Intensity-ModulatedRadiation, IonizingCarcinogensRadiotherapy, ConformalRadiation ToleranceRadiotherapyTreatment OutcomeAneuploidyCell Transformation, NeoplasticCombined Modality TherapyRadiationRadiation OncologyRadiation ProtectionRisk AssessmentRadiation MonitoringPhantoms, ImagingRadiotherapy, AdjuvantDose FractionationGenetic TherapyRisk FactorsProstatic NeoplasmsTime FactorsNeoplasms, Radiation-InducedRadiation PneumonitisBreast NeoplasmsEarly Detection of CancerBrachytherapyNeoplasm Recurrence, LocalLung NeoplasmsNeoplasm StagingRadiation-Sensitizing AgentsRadiation Injuries, ExperimentalSurvival AnalysisRadiosurgeryRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsSurvival RateCarcinoma, Squamous CellHead and Neck NeoplasmsGamma RaysCosmic RadiationFollow-Up StudiesBrain NeoplasmsNeoplasm MetastasisPrognosisDisease-Free SurvivalRadiotherapy, Computer-AssistedOvarian NeoplasmsAntineoplastic AgentsCranial IrradiationPancreatic NeoplasmsRadiotherapy, Image-GuidedChemotherapy, AdjuvantMice, NudeColonic NeoplasmsNeoplasm InvasivenessParticle AcceleratorsStomach NeoplasmsCarcinoma, Non-Small-Cell LungUterine Cervical NeoplasmsRectal NeoplasmsRadiodermatitisRadiation-Protective AgentsRadiotherapy, High-EnergyAdenocarcinomaBackground RadiationCisplatinCell Line, TumorCarcinomaTumor BurdenProstate-Specific AntigenGene Expression Regulation, NeoplasticOrgans at RiskChemoradiotherapyTomography, X-Ray ComputedFluorouracilProspective StudiesCancer VaccinesNeoplasms, Second PrimaryCobalt RadioisotopesRiskCell SurvivalMastectomy, SegmentalSurvivorsDisease ProgressionXenograft Model Antitumor AssaysNeoplasm ProteinsRadiation EffectsSEER Program